{"id":3942,"date":"2026-02-02T11:21:36","date_gmt":"2026-02-02T11:21:36","guid":{"rendered":"https:\/\/arkreflectionsias.com\/studentportal\/?p=3942"},"modified":"2026-02-05T09:59:45","modified_gmt":"2026-02-05T09:59:45","slug":"current-affairs-2nd-february-2026","status":"publish","type":"post","link":"https:\/\/arkreflectionsias.com\/studentportal\/2026\/02\/02\/current-affairs-2nd-february-2026\/","title":{"rendered":"Current Affairs 2nd February 2026"},"content":{"rendered":"<h2><span style=\"text-decoration: underline;\">1. Biopharma SHAKTI<\/span><\/h2>\n<p>GS Paper III-Biotechnology \u00a0-Health<\/p>\n<p>Context : Budget 2026-27 launches \u20b910,000cr Biopharma SHAKTI amid India&#8217;s NCD surge (diabetes\/cancer), biologics import reliance, and push for self-reliant biopharma hub\u2014<\/p>\n<p><strong>SHAKTI Initiative Overview<\/strong><\/p>\n<ul>\n<li>Strategy for Healthcare Advancement via Knowledge, Technology &amp; Innovation.<\/li>\n<li>Targets India as global biologics\/biosimilars manufacturing leader over 5 years.<\/li>\n<\/ul>\n<p><strong>Core Ecosystem Build<\/strong><\/p>\n<ul>\n<li>3 new NIPERs + upgrades to 7 existing for biopharma-focused training.<\/li>\n<li>1000+ accredited clinical trial sites nationwide.<\/li>\n<li>Spurs advanced biomanufacturing infra and next-gen therapy innovation.<\/li>\n<\/ul>\n<p><strong>Biologics Explained<\/strong><\/p>\n<ul>\n<li>Complex drugs from living organisms; tough production limits access to rich nations.<\/li>\n<\/ul>\n<p><strong>Biosimilars Defined<\/strong><\/p>\n<ul>\n<li>Near-identical biologic copies via rigorous tests; cut costs, boost competition\/safety.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span style=\"text-decoration: underline;\">2. Why is India -EU trade agreement significant ?<\/span><\/h2>\n<p>GS PAPER II-IR<\/p>\n<p><strong>CONTEXT :<\/strong>India-EU FTA concluded January 27, 2026, after 20 years\u2014linking 4th (India) &amp; 2nd (EU) largest economies ($24T combined market)\u2014boosts $136B goods + $83B services trade amid US tariff hikes;<\/p>\n<p><strong>&#8216;Mother of All Deals&#8217; Rationale<\/strong><\/p>\n<ul>\n<li>Covers massive $220B bilateral trade; EU alone = 12% of India&#8217;s total vs 16% from 8 prior FTAs.<\/li>\n<li>Zero duties on 90.7% Indian exports Day 1; 99% total coverage via phases\/quotas.<\/li>\n<\/ul>\n<p><strong>India&#8217;s Key Gains<\/strong><\/p>\n<ul>\n<li>EU cuts duties on 70.4% lines (90.7% export value) immediately; 20.3% phased 3-5 yrs (foods\/marine).<\/li>\n<li>Partial\/quota access for 6.1% lines (poultry\/veg\/auto\/steel\/shrimp); services open in 144 sub-sectors (IT\/professional).<\/li>\n<li>Labour-intensive sectors gain $35B (textiles\/leather\/chemicals\/gems); agri (tea\/spices\/fruits) gets preferences; AYUSH pros can practice in unregulated EU states.<\/li>\n<\/ul>\n<p><strong>India&#8217;s Concessions to EU<\/strong><\/p>\n<ul>\n<li>Zero duties on 49.6% lines (30.6% trade value) Day 1; 39.5% phased 5-10 yrs (97.5% total coverage).<\/li>\n<li>Wine duties drop to 30% (\u20ac2.5-10) or 20% (above \u20ac10) over 7 yrs within quotas; cheap wine excluded.<\/li>\n<li>Auto tariffs from 110% to 10% gradually under quotas; cars &lt;\u20b925L protected, luxury gets bigger quotas.<\/li>\n<\/ul>\n<p><strong>Excluded Sensitive Sectors<\/strong><\/p>\n<ul>\n<li>India bars beef\/poultry\/dairy\/fish\/cereals\/fruits\/nuts\/oils\/tea\/coffee\/spices\/tobacco.<\/li>\n<li>EU excludes beef\/sugar\/rice\/chicken\/milk\/honey\/bananas\/wheat\/garlic\/ethanol; quotas for sheep\/grapes\/onions\/rum.<\/li>\n<\/ul>\n<p><strong>Lingering Concerns<\/strong><\/p>\n<ul>\n<li>CBAM carbon tariffs unresolved; India secures MFN\u2014any concession to others auto-applies here.<\/li>\n<li>Needs reforms in ease of business\/infra to attract supply chain shifts post-FTA.<\/li>\n<li>Domestic protection via quotas\/phases balances gains without flooding sensitive markets.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span style=\"text-decoration: underline;\">3. Indias battery scheme for EVs<\/span><\/h2>\n<p>GS III- S&amp;T\/Economy.<\/p>\n<p><strong>Context : <\/strong>India&#8217;s \u20b918,100 crore ACC PLI scheme for EV batteries hits snags\u20141.4\/50 GWh achieved, zero incentives paid, just 1,118 jobs created\u2014exposing import reliance amid Budget 2026&#8217;s electronics push and global supply risks;<\/p>\n<p><strong>ACC Technology Basics<\/strong><\/p>\n<ul>\n<li>Next-gen cells store\/release electricity chemically; tech-agnostic (Li-ion, NMC, LFP, sodium-ion).<\/li>\n<li>Targets cathodes\/anodes\/electrolytes to cut Chinese import dependence for EVs\/storage.<\/li>\n<\/ul>\n<p><strong>Scheme Goals vs Reality<\/strong><\/p>\n<ul>\n<li>Launched 2021: 50 GWh by 2025, \u20b92,900cr incentives planned; only 2.8% (1.4 GWh, Ola Electric) commissioned.<\/li>\n<li>8.6 GWh delayed, 20 GWh stalled; 25% target investment, minimal jobs despite gigafactory ambitions.<\/li>\n<\/ul>\n<p><strong>Auction and Mechanics<\/strong><\/p>\n<ul>\n<li>Winners: Ola (20 GWh), Reliance (25 GWh total), Rajesh Exports (5 GWh); min 5 GWh commitment, net worth tests.<\/li>\n<li>Subsidies up to \u20b92,000\/kWh for sales; mandates 25% DVA in 2 yrs, 60% by yr 5 for localisation.<\/li>\n<\/ul>\n<p><strong>Key Failure Drivers<\/strong><\/p>\n<ul>\n<li>Unrealistic 2-yr timelines for greenfield gigafactories in immature ecosystem.<\/li>\n<li>Tough DVA norms amid missing lithium\/nickel\/cobalt refining capacity.<\/li>\n<li>Criteria favoured novices over veterans like Exide\/Amara Raja.<\/li>\n<li>China reliance for inputs\/tech; visa delays block Chinese experts amid skill shortages.<\/li>\n<li>Weak foundational capabilities delay commissioning across beneficiaries.<\/li>\n<\/ul>\n<p><strong>Revival Proposals<\/strong><\/p>\n<ul>\n<li>Short-term: Extend timelines by 1 yr, fast-track expert visas, waive early penalties.<\/li>\n<li>Long-term: Boost mineral refining schemes, component PLIs, R&amp;D\/skilling investments.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span style=\"text-decoration: underline;\">4. Bharat-VISTAAR<\/span><\/h2>\n<p><strong>Context :<\/strong>Budget 2026-27 launches Bharat-VISTAAR, a multilingual AI tool integrating AgriStack and ICAR practices, to boost farmer productivity amid India&#8217;s agri-reform push\u2014key UPSC agriculture\/tech current affairs topic.<\/p>\n<p><strong>Bharat-VISTAAR Overview<\/strong><\/p>\n<ul>\n<li>Virtually Integrated System to Access Agricultural Resources.<\/li>\n<li>AI-driven, multilingual platform linking AgriStack portals with ICAR agronomy packages.<\/li>\n<\/ul>\n<p><strong>Key Benefits<\/strong><\/p>\n<ul>\n<li>Custom advisory elevates farm yields and decision-making.<\/li>\n<li>Risk reduction via personalised, data-backed farmer support.<\/li>\n<\/ul>\n<p><strong>AgriStack Foundation<\/strong><\/p>\n<ul>\n<li>Digital backbone uniting stakeholders for superior agri outcomes.<\/li>\n<li>Enables cheap credit, quality inputs, localised advice, market access.<\/li>\n<li>Streamlines govt schemes delivery and agri planning.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span style=\"text-decoration: underline;\">5. Divyangjan Kaushal Yojana<\/span><\/h2>\n<p>GS paper II-social justice<\/p>\n<p><strong>Context :<\/strong>Budget 2026-27 launches Divyangjan Kaushal Yojana (\u20b9200cr) and Divyang Sahara Yojana (\u20b9100cr) to skill\/train PwDs and boost assistive tech via ALIMCO<\/p>\n<p><strong>Divyangjan Kaushal Yojana<\/strong><\/p>\n<ul>\n<li>Targets skill training for dignified livelihoods among persons with disabilities.<img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-3943 alignright\" src=\"https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-02-165030-300x167.png\" alt=\"\" width=\"392\" height=\"218\" srcset=\"https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-02-165030-300x167.png 300w, https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/Screenshot-2026-02-02-165030.png 457w\" sizes=\"(max-width: 392px) 100vw, 392px\" \/><\/li>\n<li>Offers \u20b9200 crore; provides industry-specific, customised training by disability group.<\/li>\n<\/ul>\n<p><strong>Covered Sectors<\/strong><\/p>\n<ul>\n<li>IT, AVGC (animation\/VFX\/gaming\/comics), hospitality, food &amp; beverages.<\/li>\n<li>Focuses task-oriented, process-driven roles for employability.<\/li>\n<\/ul>\n<p><strong>Divyang Sahara Yojana<\/strong><\/p>\n<ul>\n<li>Allocates \u20b9100 crore to scale ALIMCO&#8217;s high-quality assistive devices.<\/li>\n<li>Integrates AI into R&amp;D, product design; strengthens PM Divyasha Kendras.<\/li>\n<\/ul>\n<p><strong>PM Divyasha Kendra Role<\/strong><\/p>\n<ul>\n<li>One-stop ALIMCO centres for assessment, counselling, aid distribution, post-care.<\/li>\n<li>Adds Assistive Technology Marts as retail hubs for PwDs\/seniors to test\/buy devices.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span style=\"text-decoration: underline;\">6. Debating budget 2026 as turning point or tinkering<\/span><\/h2>\n<p>GS PAPER III-economy -budget<\/p>\n<p><strong>Context :<\/strong>Budget 2026\u201327, presented amid Trump&#8217;s second-term trade disruptions, China&#8217;s export curbs, and India&#8217;s manufacturing slump, signals policy shifts toward self-reliance and industrial revival.<\/p>\n<p><strong>Geopolitical Shifts Driving Policy<\/strong><\/p>\n<ul>\n<li>Trump&#8217;s renewed presidency sparks global trade chaos, straining India&#8217;s US ties and labour-export hopes.<\/li>\n<li>Russia relations pressured; US tariffs hit Indian exports, pushing diversification needs.<\/li>\n<li>China import reliance persists despite curbs; new restrictions on minerals\/machinery expose EV vulnerabilities.<\/li>\n<li>Budget prioritises import cuts, trade streamlining, and local production to merge economic-strategic goals.<\/li>\n<\/ul>\n<p><strong>Manufacturing Slump and Core Issues<\/strong><\/p>\n<ul>\n<li>GDP growth hides deindustrialisation: manufacturing output share stagnant, jobs declining.<\/li>\n<li>ASI data reveals slower factory growth than official figures, signaling hidden weaknesses.<\/li>\n<li>Low fixed investment erodes capacity; heavy import reliance on capital goods hampers output.<\/li>\n<li>Inverted duties (higher on intermediates) deter value addition; Make in India\/PLI yield only assembly wins.<\/li>\n<\/ul>\n<p><strong>Key Budget Fixes and Shortfalls<\/strong><\/p>\n<p><strong>Tariff and Process Tweaks<\/strong><\/p>\n<ul>\n<li>Cuts duties on capital\/intermediate goods to fix production distortions and boost efficiency.<\/li>\n<li>Port delay reductions and import simplifications aim to enhance trade edge.<\/li>\n<\/ul>\n<p><strong>Electronics Supply Chain Push<\/strong><\/p>\n<ul>\n<li>Rare-earths corridor in mineral States to build mining-processing-manufacturing chain.<\/li>\n<li>Tax breaks for lithium-battery capital goods strengthen critical EV supply lines.<\/li>\n<\/ul>\n<p><strong>Labour Sector and MSME Boost<\/strong><\/p>\n<ul>\n<li>New clusters, legacy upgrades, and capital access for MSMEs to lift productivity.<\/li>\n<li>Targets job-rich sectors for trade diversification, but needs scale\/skills\/infra support.<\/li>\n<\/ul>\n<p><strong>Investment and Fiscal Gaps<\/strong><\/p>\n<ul>\n<li>Lacks bold incentives amid falling FDI\/GDP; global climate deters multinational tech inflows.<\/li>\n<li>SEZ domestic sales allowance dilutes export focus, risking long-term trade weakness.<\/li>\n<li>Ignores Centre-State fiscal ties; pending 16th Finance Commission leaves investment coordination hanging.<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong>Budget cautiously tackles industrial woes and import risks via tariffs\/electronics\/MSMEs, but success depends on execution, FDI revival, and federal alignment for true transformation.<\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"text-decoration: underline;\">7. Budget 2026 bets big on Industrial growth<\/span><\/h2>\n<p>GS paper III-Economy<\/p>\n<p><strong>Context :<\/strong>Union Budget 2026\u201327, unveiled amid India&#8217;s climb to 4th largest economy, high growth (10%+ nominal GDP), and global tariff risks, prioritises capex continuity and manufacturing revival.<\/p>\n<p><strong>Strong Economy Meets Hidden Risks<\/strong><\/p>\n<ul>\n<li>High growth\/low inflation phase boosts optimism, but geopolitical tensions and supply disruptions threaten sustained expansion.<\/li>\n<li>Budget balances continuity with vision, blending infra push, welfare tweaks, and realism against external shocks.<\/li>\n<\/ul>\n<p><strong>Capex Surge with Deficit Control<\/strong><\/p>\n<ul>\n<li>Capex jumps to \u20b912.2 lakh crore for FY27, driving infra-led growth continuity.<\/li>\n<li>Fiscal deficit targets 4.3% GDP, aligning with debt reduction path; assumes &gt;10% nominal GDP growth.<\/li>\n<li>High borrowings limit RBI rate cuts, highlighting fiscal-monetary policy tightrope.<\/li>\n<\/ul>\n<p><strong>Manufacturing and Key Sector Drive<\/strong><\/p>\n<ul>\n<li>Targets semiconductors, electronics, biopharma, chemicals, capital goods, textiles, and MSMEs for broad production base.<\/li>\n<li>India Semiconductor Mission 2.0, electronics boosts cut global supply chain reliance.<\/li>\n<li>Logistics\/freight corridors, container focus, SME fund, and tariff-hit export aid enhance trade edge.<\/li>\n<\/ul>\n<p><strong>Policy Inconsistencies Exposed<\/strong><\/p>\n<ul>\n<li>Disinvestment revenue targets overly optimistic despite past misses.<\/li>\n<li>Tax breaks for cloud providers via Indian data centres spark revenue loss concerns.<\/li>\n<li>Services job hopes clash with AI\/automation trends reducing labour needs.<\/li>\n<li>Data centre push ignores matching power generation despite high energy demands.<\/li>\n<li>No rupee volatility fix despite macro risks.<\/li>\n<\/ul>\n<p><strong>Demand and Execution Weak Spots<\/strong><\/p>\n<ul>\n<li>Lacks full industrial policy; risks fragmented manufacturing efforts.<\/li>\n<li>Minimal demand-side measures despite need for domestic income\/jobs to fuel expansion.<\/li>\n<li>Capex execution shortfalls curb multipliers; price rises erode purchasing power.<\/li>\n<li>Global uncertainty demands stronger consumption support for resilience.<\/li>\n<\/ul>\n<p><strong>Conclusion\u00a0 <\/strong><\/p>\n<p>Budget advances infra\/manufacturing stability but optimistic assumptions, contradictions, and demand gaps limit transformation. Success hinges on execution, demand revival, and policy alignment for inclusive growth.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1. Biopharma SHAKTI GS Paper III-Biotechnology \u00a0-Health Context : Budget 2026-27 launches \u20b910,000cr Biopharma SHAKTI amid India&#8217;s NCD<\/p>\n","protected":false},"author":2,"featured_media":3956,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3942","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-daily-current-affairs"],"featured_image_urls":{"full":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we.png",1024,1024,false],"thumbnail":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we-150x150.png",150,150,true],"medium":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we-300x300.png",300,300,true],"medium_large":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we-768x768.png",640,640,true],"large":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we.png",640,640,false],"1536x1536":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we.png",1024,1024,false],"2048x2048":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we.png",1024,1024,false],"morenews-large":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we-825x575.png",825,575,true],"morenews-medium":["https:\/\/arkreflectionsias.com\/studentportal\/wp-content\/uploads\/2026\/02\/b_Biopharma_SHAKTI_we-590x410.png",590,410,true]},"author_info":{"display_name":"Nithin DTPoperator","author_link":"https:\/\/arkreflectionsias.com\/studentportal\/author\/nithindtp\/"},"category_info":"<a href=\"https:\/\/arkreflectionsias.com\/studentportal\/category\/daily-current-affairs\/\" rel=\"category tag\">DAILY CURRENT AFFAIRS<\/a>","tag_info":"DAILY CURRENT AFFAIRS","comment_count":"0","_links":{"self":[{"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/posts\/3942","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/comments?post=3942"}],"version-history":[{"count":1,"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/posts\/3942\/revisions"}],"predecessor-version":[{"id":3944,"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/posts\/3942\/revisions\/3944"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/media\/3956"}],"wp:attachment":[{"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/media?parent=3942"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/categories?post=3942"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arkreflectionsias.com\/studentportal\/wp-json\/wp\/v2\/tags?post=3942"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}